Examining the potential of the influenza vaccine for secondary prevention: a myocardial infarction vaccine?
Arintaya
A
Phrommintikul
Wanwarang
W
Wongcharoen
D003324:Coronary Artery Disease / Q000517:prevention & control; D018450:Disease Progression; D015195:Drug Design; D006801:Humans; D007249:Inflammation / Q000517:prevention & control; D007252:Influenza Vaccines; D009203:Myocardial Infarction / Q000517:prevention & control*; D012307:Risk Factors; D040242:Risk Reduction Behavior; D055502:Secondary Prevention / Q000379:methods*
D007252:Influenza Vaccines